Medicines, 2014
Shortlist up to four to read them side by side.
1,562 medicine recalls FDA’s Enforcement Report published in 2014, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 6, 2026.
1,562of 1,562 medicine recallsshown with your filters
The list
- Medicine recall LEVOTHYROXINE SODIUM, Tablet, 125 mcg Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 125 mcg may have potentially been mislabeled as the following drug: MAGNESIUM CHLORIDE DR, Tablet, 64 mg,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LEVOTHYROXINE SODIUM, Tablet, 175 mcg Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 175 mcg may have potentially been mislabeled as the following drug: CINACALCET HCL, Tablet, 60 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LEVOTHYROXINE SODIUM, Tablet, 112 mcg Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 112 mcg may have potentially been mislabeled as the following drug: MULTIVITAMIN/MULTIMINERAL, Tablet, 0… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall RILUZOLE, Tablet, 50 mg Labeling: Label Mixup: RILUZOLE, Tablet, 50 mg may have potentially been mislabeled as the following drug: LACTOBACILLUS, Tablet, 0 mg, NDC 64980012950,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall FLUVASTATIN SODIUM, Capsule, 20 mg Labeling: Label Mixup: FLUVASTATIN SODIUM, Capsule, 20 mg may have potentially been mislabeled as the following drug: VALSARTAN, Tablet, 80 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall VALSARTAN, Tablet, 80 mg Labeling: Label Mixup: VALSARTAN, Tablet, 80 mg may have potentially been mislabeled as one of the following drugs: TEMAZEPAM, Capsule, 7.5 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall VALSARTAN, Tablet, 160 mg Labeling: Label Mixup: VALSARTAN, Tablet, 160 mg may have potentially been mislabeled as one of the following drugs: PROGESTERONE, Capsule, 100 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall VALSARTAN, Tablet, 320 mg Labeling: Label Mixup: VALSARTAN, Tablet, 320 mg may have potentially been mislabeled as the following drug: CILOSTAZOL, Tablet, 100 mg, NDC 60505252201,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall MYCOPHENOLIC ACID DR, Tablet, 180 mg Labeling: Label Mixup: MYCOPHENOLIC ACID DR, Tablet, 180 mg may have potentially been mislabeled as the following drug: METHAZOLAMIDE, Tablet, 50 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall VALSARTAN, Tablet, 40 mg Labeling: Label Mixup: VALSARTAN, Tablet, 40 mg may have potentially been mislabeled as one of the following drugs: VALSARTAN, Tablet, 80 mg, NDC 00078035834,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall carBAMazepine ER, Tablet, 100 mg Labeling: Label Mixup: carBAMazepine ER, Tablet, 100 mg may have potentially been mislabeled as one of the following drugs: ISOSORBIDE DINITRATE ER, Tablet, 40… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall DESLORATADINE, Tablet, 5 mg Labeling: Label Mixup: DESLORATADINE, Tablet, 5 mg may have potentially been mislabeled as the following drug: ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall VENLAFAXINE HCL, Tablet, 25 mg Labeling: Label Mixup: VENLAFAXINE HCL, Tablet, 25 mg may have potentially been mislabeled as one of the following drugs: sitaGLIPtin PHOSPHATE, Tablet, 50 mg,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall CARBIDOPA/LEVODOPA, Tablet, 25 mg/250 mg Labeling: Label Mixup: CARBIDOPA/LEVODOPA, Tablet, 25 mg/250 mg may have potentially been mislabeled as the following drug: DIGOXIN, Tablet, 0.125 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall DILTIAZEM HCL, Tablet, 120 mg Labeling: Label Mixup: DILTIAZEM HCL, Tablet, 120 mg, may have potentially been mislabeled as the following drug: NICOTINE POLACRILEX, LOZENGE, 2 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall METOPROLOL TARTRATE, Tablet, 50 mg Labeling: Label Mixup: METOPROLOL TARTRATE, Tablet, 50 mg may have potentially been mislabeled as one of the following drugs: METOPROLOL TARTRATE, Tablet, 25… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall PIROXICAM, Capsule, 10 mg Labeling: Label Mixup: PIROXICAM, Capsule, 10 mg may have potentially been mislabeled as the following drug: HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall NORTRIPTYLINE HCL, Capsule, 10 mg Labeling: Label Mixup: NORTRIPTYLINE HCL, Capsule, 10 mg may have potentially been mislabeled as the following drug: VALSARTAN, Tablet, 80 mg, NDC 00078035834,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall NORTRIPTYLINE HCL, Capsule, 50 mg Labeling: Label Mixup: NORTRIPTYLINE HCL, Capsule, 50 mg may have potentially been mislabeled as one of the following drugs: ROSUVASTATIN CALCIUM, Tablet, 5… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall NORTRIPTYLINE HCL, Capsule, 75 mg Labeling: Label Mixup: NORTRIPTYLINE HCL, Capsule, 75 mg may have potentially been mislabeled as one of the following drugs: guaiFENesin ER, Tablet, 600 mg,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall clonazePAM, Tablet, 0.25 mg Labeling: Label Mixup: clonazePAM, Tablet, 0.25 mg (1/2 of 0.5 mg) may have potentially been mislabeled as the following drug: CHOLECALCIFEROL, Capsule, 2000… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall NEFAZODONE HCL, Tablet, 200 mg Labeling: Label Mixup: NEFAZODONE HCL, Tablet, 200 mg may have potentially been mislabeled as the following drug: NEFAZODONE HCL, Tablet, 150 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall SOTALOL HCL, Tablet, 120 mg Labeling: Label Mixup: SOTALOL HCL, Tablet, 120 mg may have potentially been mislabeled as the following drug: NEOMYCIN SULFATE, Tablet, 500 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall SOTALOL HCL, Tablet, 80 mg Labeling: Label Mixup: SOTALOL HCL, Tablet, 80 mg may have potentially been mislabeled as one of the following drugs: DILTIAZEM HCL, Tablet, 120 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall SOTALOL HCL, Tablet, 160 mg Labeling: Label Mixup: SOTALOL HCL, Tablet, 160 mg may have potentially been mislabeled as the following drug: DISULFIRAM, Tablet, 250 mg, NDC 64980017101,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall PIOGLITAZONE HCL, Tablet, 15 mg Labeling: Label Mixup: PIOGLITAZONE HCL, Tablet, 15 mg may have potentially been mislabeled as one of the following drugs: DOXYCYCLINE MONOHYDRATE, Capsule,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall DISOPYRAMIDE PHOSPHATE, Capsule, 150 mg Labeling: Label Mixup: DISOPYRAMIDE PHOSPHATE, Capsule, 150 mg may have potentially been mislabeled as the following drug: THYROID, Tablet, 30 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall BUMETANIDE, Tablet, 0.5 mg Labeling: Label Mixup: BUMETANIDE, Tablet, 0.5 mg, Rx only may have potentially been mislabeled as the following drug: ERYTHROMYCIN DR EC, Tablet, 250 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall BUMETANIDE, Tablet, 1 mg Labeling: Label Mixup: BUMETANIDE, Tablet, 1 mg may have potentially been mislabeled as the following drug: guaiFENesin ER, Tablet, 600 mg, NDC 63824000815,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall ESCITALOPRAM, Tablet, 5 mg Labeling: Label Mixup: ESCITALOPRAM, Tablet, 5 mgmay have potentially been mislabeled as the following drug: SODIUM CHLORIDE, Tablet, 1 gm, NDC 00223176001,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall NEFAZODONE HCL, Tablet, 150 mg Labeling: Label Mixup: NEFAZODONE HCL, Tablet, 150 mg may have potentially been mislabeled as the following drug: LIOTHYRONINE SODIUM, Tablet, 25 mcg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall SIMVASTATIN, Tablet, 5 mg Labeling: Label Mixup: SIMVASTATIN, Tablet, 5 mg may have potentially been mislabeled as the following drug: LOSARTAN POTASSIUM, Tablet, 25 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall SIMVASTATIN, Tablet, 40 mg Labeling: Label Mixup: SIMVASTATIN, Tablet, 40 mg may have potentially been mislabeled as the following drug: METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall amLODIPine BESYLATE, Tablet, 5 mg Labeling: Label Mixup: amLODIPine BESYLATE, Tablet, 5 mg may have potentially been mislabeled as the following drug: CYANOCOBALAMIN, Tablet, 1000 mcg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LOSARTAN POTASSIUM, Tablet, 25 mg Labeling: Label Mixup: LOSARTAN POTASSIUM, Tablet, 25 mg may have potentially been mislabeled as the following drug: PHYTONADIONE, Tablet, 5 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LOSARTAN POTASSIUM, Tablet, 50 mg Labeling: Label Mixup: LOSARTAN POTASSIUM, Tablet, 50 mg may have potentially been mislabeled as the following drug: MIDODRINE HCL, Tablet, 2.5 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall VENLAFAXINE HCL, Tablet, 75 mg Labeling: Label Mixup: VENLAFAXINE HCL, Tablet, 75 mg may have potentially been mislabeled as the following drug: TACROLIMUS, Capsule, 1 mg, NDC 00781210301,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall VENLAFAXINE HCL, Tablet, 100 mg Labeling: Label Mixup: VENLAFAXINE HCL, Tablet, 100 mg may have potentially was mislabeled as tiZANidine HCl, Tablet, 2 mg, NDC 55111017915, Pedigree:… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall VENLAFAXINE HCL ER, Capsule, 150 mg Labeling: Label Mixup: VENLAFAXINE HCL ER, Capsule, 150 mg may have potentially been mislabeled as one of the following drugs: SOTALOL HCL, Tablet, 80 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall IRBESARTAN, Tablet, 150 mg Labeling: Label Mixup: IRBESARTAN, Tablet, 150 mg may have potentially been mislabeled as the following drug: BENAZEPRIL HCL, Tablet, 40 mg, NDC 65162075410,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall glyBURIDE MICRONIZED, Tablet, 3 mg Labeling: Label Mixup: glyBURIDE MICRONIZED, Tablet, 3 mg may have potentially been mislabeled as the following drug: DIGOXIN, Tablet, 0.125 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall FAMCICLOVIR, Tablet, 500 mg Labeling: Label Mixup: FAMCICLOVIR, Tablet, 500 mg may have potentially been mislabeled as one of the following drugs: TOLTERODINE TARTRATE ER, Capsule, 4 mg,… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall DOXAZOSIN MESYLATE, Tablet, 1 mg, Over The Counter Labeling: Label Mixup: DOXAZOSIN MESYLATE, Tablet, 1 mg may have potentially been mislabeled as the following drug: PYRIDOXINE HCL, Tablet, 100 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall glyBURIDE, Tablet, 1.25 mg Labeling: Label Mixup: glyBURIDE, Tablet, 1.25 mg may have potentially been mislabeled as one of the following drugs: CYPROHEPTADINE HCL, Tablet, 4 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall glyBURIDE, Tablet, 2.5 mg Labeling: Label Mixup: glyBURIDE, Tablet, 2.5 mg may have potentially been mislabeled as one of the following drugs: sulfaSALAzine, Tablet, 500 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall MEXILETINE HCL, Capsule, 150 mg Labeling: Label Mixup: MEXILETINE HCL, Capsule, 150 mg may have potentially been mislabeled as the following drug: CALCIUM ACETATE, Capsule, 667 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall MEXILETINE HCL, Capsule, 200 mg Labeling: Label Mixup: MEXILETINE HCL, Capsule, 200 mg may have potentially been mislabeled as the following drug: ISOSORBIDE DINITRATE, Tablet, 10 mg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall ACYCLOVIR, Capsule, 200 mg Labeling: Label Mixup: ACYCLOVIR, Capsule, 200 mg may have potentially been mislabeled as one of the following drugs: CYANOCOBALAMIN, Tablet, 1000 mcg, NDC… Class IIFDA’s classJan 29, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 29, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.